Qiming U.S. Healthcare Fund II, L.P.

CIK 1765710 · last filed 2023-04-11

Qiming U.S. Healthcare Fund II, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider bought $16.0M of JSPRW on Apr 11, 2023. Across all open-market trades the lifetime net is +$26.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $114.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$114.2K

Companies

2

Total Filings

2

Lifetime Open-Market Net

$26.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
JSPRW 10%+ Owner 8,519,648 $0.01 $114.2K $16.00M 1 2023-04-11
Elevation Oncology, Inc. (ELEV) Delisted 10%+ Owner 2,370,142 $0.36 $865.1K $10.00M 1 2021-07-01

Recent Filings

2 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-04-11 JSPRW Buy (P) +10,666,664 $16.00M EDGAR
2021-07-01 Elevation Oncology, Inc. (ELEV) Delisted Mixed +4,740,284 $10.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.